NCT06005207 - Vaginal Progesterone Improves Clinical Outcomes of RIF Patients | Biotech Hunter

Enrollment

152

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Infertility, Female

Interventions

DRUG

progesterone vaginal sustained-release gel

90 mg progesterone vaginal sustained-release gel is added daily during endometrial transformation and luteal support

Trial Locations (1)

RECRUITING

Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School, Nanjing

All Listed Sponsors

lead

Nanjing University

OTHER